Amgen's Heart Drug Lowers Patient Cholesterol in Study

Published November 12, 2012

Amgen's Heart Drug Lowers Patient Cholesterol in Study

Filed under: drug treatment news 2012

Amgen's Heart Drug Lowers Patient Cholesterol in Study. By Ryan Flinn – 2012-11-06T15:46:00Z … Some of the patients were also taking Merck & Co.'s cholesterol treatment Zetia. Amgen's drug is one of several that companies are developing to target the …
Read more on Bloomberg

Drug trio improved effectiveness of cancer treatment, protected heart

Filed under: drug treatment news 2012

6, 2012 — Combining cancer medication with a drug for erectile dysfunction and one for heart transplants helped kill cancer cells and protected the heart from damage, in a study presented at the American Heart Association's Scientific Sessions 2012.
Read more on Bioscience Technology

PropThink: Titan Files NDA on Probuphine; Partner Waits

Filed under: drug treatment news 2012

By Jason Napodano, CFA. Monday morning, Titan Pharmaceuticals (OTC:TTNP) announced it had filed a New Drug Application (NDA) to the U.S. FDA on Probuphine for the maintenance treatment of opioid dependence in adults patients (Press Release). … In …
Read more on Reuters